SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: HerbertOtto who wrote (21111)5/19/1998 12:33:00 PM
From: Henry Niman  Respond to of 32384
 
The combo treatment of breast cancer with Tamoxifen and Panretin and some Targretin data is slated for today at ASCO.



To: HerbertOtto who wrote (21111)5/19/1998 12:54:00 PM
From: Henry Niman  Read Replies (2) | Respond to of 32384
 
Herbert, I think that the Targretin data was yesterday. The abstracts that Stan uploaded indicate that only the Panretin/Tamoxifen treatment of human breast cancer will be presented today.